PUBLISHER: The Business Research Company | PRODUCT CODE: 1942779
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942779
Elastomeric infusion pumps are medical devices designed for the controlled delivery of medications or fluids over a specified duration. They are appreciated for their simplicity, portability, and user-friendliness, making them valuable in both hospital and home care environments. These pumps facilitate treatment outside clinical settings, offering patients greater mobility and flexibility during infusion therapy.
The primary types of elastomeric infusion pumps are continuous-rate and variable-rate pumps. Variable-rate pumps allow healthcare providers to adjust the infusion rates by altering the pressure within the elastomeric balloon or using different flow restrictors, ensuring treatment is customized to meet individual patient needs. These pumps are utilized in various treatments, including pain management, antibiotics or antivirals, chemotherapy, and more, and are employed across different settings such as hospitals, ambulatory surgical centers, home care environments, and clinics.
Tariffs are impacting the elastomeric infusion pumps market by increasing the cost of imported elastomeric materials, medical-grade plastics, and precision manufacturing components. These effects are most evident across continuous and variable rate pump segments, particularly in regions dependent on cross-border medical device supply chains such as Asia-Pacific and Europe. Higher tariffs have moderately increased procurement costs for hospitals and home care providers. At the same time, tariffs are encouraging localized manufacturing, alternative material sourcing, and supply chain diversification, supporting long-term market stability.
The elastomeric infusion pumps market research report is one of a series of new reports from The Business Research Company that provides elastomeric infusion pumps market statistics, including elastomeric infusion pumps industry global market size, regional shares, competitors with a elastomeric infusion pumps market share, detailed elastomeric infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the elastomeric infusion pumps industry. This elastomeric infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The elastomeric infusion pumps market size has grown strongly in recent years. It will grow from $1.16 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to growth in chronic disease treatment needs, increasing use of infusion-based therapies, expansion of hospital outpatient services, rising demand for pain management solutions, improved availability of elastomeric pump devices.
The elastomeric infusion pumps market size is expected to see strong growth in the next few years. It will grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing preference for homecare treatment models, rising demand for chemotherapy outside hospital settings, growth in ambulatory surgical centers, increasing healthcare focus on patient mobility and comfort, rising healthcare expenditure on infusion therapies. Major trends in the forecast period include rising adoption of home-based infusion therapy, growing preference for portable and disposable pumps, increasing use in pain management treatments, shift toward outpatient and ambulatory care infusions, rising demand for simplified drug delivery devices.
The rising number of hospitalized patients is anticipated to boost the growth of the elastomeric infusion pump market. Hospitalized patients require medical treatment and care, which often involves ongoing monitoring and specific interventions. With advances in medical technology enabling more complex and effective treatments, there has been an increase in hospital admissions for surgeries and procedures. Elastomeric infusion pumps are designed to allow patients to receive necessary medications, such as antibiotics, pain management, or chemotherapy, at home rather than in the hospital. This capability supports early discharge, helping to free up hospital beds and reduce hospital occupancy rates. For example, in August 2025, according to a report published by the National Health Service (NHS), a UK-based government department, there were 552,592 emergency admissions, representing a 1.2% increase compared to December 2023. This growing number of hospitalizations is expected to drive the elastomeric infusion pump market.
The rising healthcare expenditure is expected to drive the growth of the elastomeric infusion pumps market in the coming years. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Spending is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often involve higher costs, contributing to greater overall healthcare spending. Higher healthcare expenditure supports the adoption of elastomeric infusion pumps by enabling hospitals and home-care providers to invest in advanced devices, access specialty therapies, and ensure proper training and maintenance. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, U.S. healthcare expenditures rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per individual. Consequently, rising healthcare expenditure is fueling growth in the elastomeric infusion pumps market.
In December 2024, Nipro Trading (Shanghai) Co., Ltd., a Japan-based medical device company, acquired Sichuan Pure Science and Technology Co., Ltd. for an undisclosed amount. Through this acquisition, Nipro Trading aims to strengthen its dialysis solutions portfolio, enhance supply chain capabilities, expand its presence in the Chinese dialysis equipment market, and improve long-term service offerings and operational efficiency. Sichuan Pure Science and Technology Co., Ltd. is a China-based medical device company that manufactures elastomeric infusion pumps.
Major companies operating in the elastomeric infusion pumps market are Baxter International Inc., Medline Industries, B. Braun Melsungen AG, Nipro Corporation, Avanos Medical Inc., Vygon SAS, pfm medical gmbh, Integrated Medical Systems Inc., Preferred Medical, Leventon S.A.U, Tuoren Medical, Eitan Medical, PROMECON GmbH, Epic Medical, Promecon Medical, Ace Medical Devices, Gamastech, Adria Med, Heka Healthcare, Beijing KellyMed Co. Ltd
North America was the largest region in the elastomeric infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the elastomeric infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the elastomeric infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The elastomeric infusion pumps market consists of sales of tubing sets, medication reservoirs, filters, needles and catheters, connectors, and adaptors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Elastomeric Infusion Pumps Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses elastomeric infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for elastomeric infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The elastomeric infusion pumps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.